These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2005-001315-22 The effect of the cholinesterase inhibitor donepezil on organic and functional deficits related to growth hormone deficiency in old age. 2009-07-31 due-trials
Ongoing 2005-001722-92 Systemic Bevacizumab (Avastin®) Therapy for Exudative Neovascular Age-Related Macular Degeneration (BEAT-AMD-Study) not-yet-due
Not reported 2006-001385-16 Rheohemapheresis and Lutein Supplementation (xantophyll carotenoid) in the Non-Exsudative Form of Age-Related Macular Degeneration. (ReLux-AMD) 2012-02-08 due-trials
Not reported 2006-001389-18 Comparison of Combined Therapy of Intravitreal Injection of Bevacizumab and Pegaptanib versus Mono-therapy (The MAAM Study) 2008-03-31 due-trials
Ongoing 2006-006760-28 Comparision of Ranibizumab (Lucentis) Monotherapy versus Combination of Ranibizumab (Lucentis) with Photodynamic Therapy (Verteporfin) in Patients with Subfoveal Choroidal Neovascularisation due to Ag... not-yet-due
Ongoing 2007-005157-33 A randomized observer and subject masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration Multicenter An... not-yet-due
Completed, but no date 2007-006288-56 Methotrexat-Polyglutamate als Marker fuer das klinische Outcome in der Therapie der rheumatoiden Arthritis bad-data
Reported results 2011-004152-19 Effects of ROFLUMILAST on markers of subclinical atherosclerosis In stable COPD; the ELASTIC-trial 2016-01-18 due-trials